US Patent 10307370 Rapamycin for the treatment of lymphangioleiomyomatosis
Patent 10307370 was granted and assigned to AI Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10307370 Rapamycin for the treatment of lymphangioleiomyomatosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
